Evidence map›Paper›PMID 35665407›Full record

ArticlePathology oncology research : POR2022

Distribution and Clinical Significance of IL-17A in Tumor-Infiltrating Lymphocytes of Non-Small Cell Lung Cancer Patients.

Rui Xu, Xing Ke, Wenwen Shang, Shuna Liu, Xin Fu, Ting Wang, Shuxian Jin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rui XuDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xing KeDepartment of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wenwen ShangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Shuna LiuDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xin FuDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ting WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Shuxian JinDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNNational Center for Clinical Laboratories · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntigens, NeoplasmCD8-Positive T-LymphocytesHumansInterleukin-17Keratin-19Lymphocytes, Tumor-Infiltratingantigen CYFRA21.1Antigens, NeoplasmInterleukin-17Keratin-19IL-17NSCLCTc17 cellsTh17 cellsTILsγδT cells

Identifiers

PMID35665407
PMCPMC9156623
OpenAlexW4280514709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.